Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Myth-buster

Calcium tied to a 7% lower colorectal cancer risk in Asian meta-analysis — but the confidence interval crossed 1.0, meaning no statistical significance

This is one of the first meta-analyses on calcium and colorectal cancer in Asian populations, and the borderline result means the protective effect is far from settled — treat the finding as hypothesis-generating, not conclusive.

The analysis pooled cohort studies and found that calcium intake was associated with a 7% reduction in colorectal cancer risk (RR 0.93), but the 95% confidence interval ranged from a 14% reduction to no effect at all (0.86–1.00), so the result is not statistically significant. Because the dose of calcium wasn't specified and the evidence is still early for this population, the link remains uncertain — it neither confirms nor rules out a small benefit.

Where this fits in the evidence

This is among the first studies we've indexed on Calcium for Reduced Risk of Colorectal Cancer — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top